Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A...

Area of Science:

• Rheumatology
• Immunology
• Medical Imaging

Background:

• The mechanisms triggering rheumatoid arthritis (RA) flares remain unclear.
• Dysfunctional lymph node (LN) drainage is implicated in joint flare in murine arthritis models.
• Investigating LN alterations in RA patients may reveal insights into disease flare and treatment response.

Purpose of the Study:

• To analyze changes in LN volume using contrast-enhanced magnetic resonance imaging (CE-MRI) in RA patients undergoing certolizumab pegol (CZP) therapy.
• To assess the correlation between LN volume changes and clinical outcomes, including pain, function, and disease activity scores.
• To determine if LN volume changes serve as a biomarker for therapeutic response in RA.

Main Methods:

• Patients with active RA joint flare were assessed at baseline and 16 weeks after CZP therapy.
• LN volumes were measured using CE-MRI.
• Changes in LN volumes were correlated with Rheumatoid and Arthritis Outcome Score (RAOS), Michigan Hand Questionnaire (MHQ), and Disease Activity Score 28 (DAS28).

Main Results:

• A significant decrease in total LN volume was observed in 70% of patients after 16 weeks of CZP therapy (mean decrease 37%).
• Improvement in knee pain (RAOS) inversely correlated with decreased popliteal LN volume (R² = 0.94).
• All patients showed significant improvement in DAS28, and notable improvements in hand function (MHQ) were recorded.

Conclusions:

• Smaller changes in LN volume during anti-TNF therapy were associated with greater knee pain relief in RA patients.
• A strong inverse correlation between LN volume and joint pain suggests LN volume dynamics are a biomarker of clinical response to RA therapy.
• This pilot study provides initial evidence supporting the use of dynamic LN volume changes as a biomarker for treatment efficacy in RA.